Clinical Trial Update: Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating the combination of aerosolized antibiotics with pembrolizumab in patients with advanced non-small cell lung cancer and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aerosolized antibiotics (unspecified)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING